Actively Recruiting
Nanopore Sequencing in Ophthalmology
Led by Medical University of Graz · Updated on 2025-09-30
20
Participants Needed
1
Research Sites
292 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this pilot study, the feasibility of the Oxford Nanopore MinION to identify pathogens from vitrectomy samples in eyes with endophthalmitis shall be assessed. The MinION is a low cost commercially available device for DNA/ RNA analysis that, in studies, has been used for pathogen determination in various infectious diseases as well as for the genetic characterization of hematologic tumors.
CONDITIONS
Official Title
Nanopore Sequencing in Ophthalmology
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Eyes of patients with endophthalmitis
You will not qualify if you...
- No informed consent possible
- Participation in other studies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Universitäts Augenklinik Graz
Graz, Styria, Austria, 8036
Actively Recruiting
Research Team
M
Michael Sommer, MD
CONTACT
G
Gerald Seidel, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here